AurorA Science
Overview
AurorA Science is a biotech investment company based in Milan, Italy, focusing on early-stage biotech startups with high therapeutic potential. The company was established in 2020 as a partnership between the technology transfer company AurorA-TT and two strategic industrial partners, Rottapharm Biotech and Italfarmaco. This collaboration aims to bridge the gap between research and industry by providing both financial and industrial support to independent and entrepreneurial biotech startups in Europe. The company's investment strategy centers on supporting final pre-clinical activities and early clinical developments, with a particular emphasis on projects that demonstrate a change of paradigm in accelerating the process of turning molecules into druggable candidates and projects into marketable products. AurorA Science seeks to partner with bio-pharma companies to create the ideal conditions for the development and commercialization of innovative therapies. AurorA Science's portfolio includes investments in companies such as InteRNA Technologies B.V., a microRNA company, and Peptomyc S.L., a biotech startup. The company operates with a team of 2-10 employees.
Investment Focus
- High therapeutic potential
- Independent and entrepreneurial biotech startups
- Final pre-clinical and early clinical development stages
Portfolio Companies
Reach AurorA Science directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about AurorA Science
What sectors does AurorA Science invest in?
AurorA Science invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Regenerative Medicine, and is based in Milano, Italy. AurorA Science is listed as a venture capital in the ConnectSafely investor database.
What stage does AurorA Science invest at?
AurorA Science backs companies at Early Stage, Series A and Series B, writing cheques of 1M - 50M.
Which regions does AurorA Science invest in?
AurorA Science invests across United Kingdom, Germany, France, Italy, Denmark and Switzerland.
What companies has AurorA Science invested in?
AurorA Science's portfolio includes InteRNA Technologies B.V. and Peptomyc S.L..
How do I contact AurorA Science?
AurorA Science's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
